Wednesday May 13, 2020
On May 13th 2020, the World Stroke Organization hosted a free webinar which offered a sneak-peek at the results of 5 large clinical trails. Please click here to view the recordings (approximately 10 minutes each).
Trial 1: Efficacy of Fluoxetine: A Randomized Controlled Trial in Stroke (EFFECTS) Assoc. Prof. Erik Lundström (Sweden) Department of Neuroscience, Neurology, Uppsala University, Akademiska Sjukhuset, Uppsala, Sweden
Trial 2: Assessment of Fluoxetine in Stroke Recovery (AFFINITY): Results of a Double-blind, Placebo-controlled, Randomised Trial Prof. Graeme Hankey (Australia) Department of Neurology, Medical School, Faculty of Health and Medical Sciences, The University of Western Australia
Trial 3: A Randomized Trial of Direct Endovascular Thrombectomy Versus Thrombectomy Preceded by Intravenous Alteplase in Acute Ischemic Stroke (DIRECT MT) Prof. Jianmin Liu (China) Changhai Hospital in Shanghai, Department of Neurosurgery, Cerebrovascular Center, China
Trial 4: The Basilar Artery International Collaboration Study (BASICS): A Randomized Controlled Trial of Endovascular Therapy in Basilar Artery Occlusion Dr. Wouter Schonewille (Netherlands) Department of Neurology, St. Antonius Hospital, Nieuwegein, The Netherlands
Trial 5: ASCOT Trial: The Effect of Randomisation to Atorvastatin or Placebo, and Amlodipine-based or Beta-blocker-based Regime on 20-year Incidence of Stroke or Dementia Dr. William Whiteley (UK) Senior Lecturer, CCBS, University of Edinburgh, Honorary Consultant Neurologist, NHS Lothian, Senior Clinical Fellow, NDPH, University of Oxford